{
    "2019-05-16": [
        [
            {
                "time": "2019-05-17",
                "original_text": "Woodward, Inc. (WWD) Ex-Dividend Date Scheduled for May 17, 2019",
                "features": {
                    "keywords": [
                        "Woodward",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-17",
                "original_text": "P & F Industries, Inc. (PFIN) Ex-Dividend Date Scheduled for May 17, 2019",
                "features": {
                    "keywords": [
                        "P & F Industries",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "GE Deal to Sell Its Biopharma Unit to Danaher Could Be at Risk, Says Analyst",
                "features": {
                    "keywords": [
                        "GE",
                        "Deal",
                        "Sell",
                        "Biopharma",
                        "Unit",
                        "Danaher",
                        "Risk",
                        "Analyst"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}